Skip to main content
SDGR logo

SDGR · Schrodinger, Inc. · Investor Relations

Track SDGR — free
Market Cap
$2.04B
Shares
75.08M
Volume · Nov 18 1.18M Avg daily vol (3M) 2.06M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-04 Schrödinger Reports Third Quarter 2026 Financial Results
2026-10-28 Schrödinger to Present at UBS Global Healthcare Conference
2026-10-26 Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-21 Schrödinger to Announce Third Quarter 2026 Financial Results on November 4
2026-10-14 Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
2026-09-17 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-09-09 Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
2026-09-01 Schrödinger to Present at Morgan Stanley Global Healthcare Conference
2026-08-14 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-08-05 Schrödinger Reports Second Quarter 2026 Financial Results
2026-08-05 Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
2026-07-27 Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
2026-07-22 Schrödinger to Announce Second Quarter 2026 Financial Results on August 5
2026-07-20 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-06-18 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-05-22 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-05-05 Schrödinger Reports First Quarter 2026 Financial Results
2026-05-04 Schrödinger to Participate in Upcoming Investor Conferences
2026-04-21 Schrödinger to Announce First Quarter 2026 Financial Results on May 5
2026-04-17 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-03-18 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-02-25 Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-02-24 Schrödinger to Participate in Upcoming Investor Conferences
2026-02-18 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-02-11 Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

Schrödinger, Inc. (Nasdaq: SDGR) will report its fourth quarter and full-year 2025 financial results on Wednesday, February 25, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and internal programs. Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations

Past events

Source: https://ir.schrodinger.com/overview/default.aspx

Key facts CIK 1490978 CUSIP 80810D103 13F (30d) 285 filings 257 filers Visit website Investor relations